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Abstract
It is unclear whether a single, brief, 15-minute episode of background anesthesia already modulates delayed secondary
processes after experimental brain injury. Therefore, this study was designed to characterize three anesthesia protocols for
their effect on molecular and histological study endpoints. Mice were randomly separated into groups that received
sevoflurane (sevo), isoflurane (iso) or an intraperitoneal anesthetic combination (midazolam, fentanyl and medetomidine;
comb) prior to traumatic brain injury (controlled cortical impact, CCI; 8 m/s, 1 mm impact depth, 3 mm diameter). Twenty-
four hours after insult, histological brain damage, neurological function (via neurological severity score), cerebral
inflammation (via real-time RT-PCR for IL6, COX-2, iNOS) and microglia (via immunohistochemical staining for Iba1) were
determined. Fifteen minutes after CCI, the brain contusion volume did not differ between the anesthetic regimens
(sevo=17.965.5 mm
3; iso=20.563.7 mm
3; comb=19.564.6 mm
3). Within 24 hours after injury, lesion size increased in all
groups (sevo=45.369.0 mm
3; iso=31.564.0 mm
3; comb=44.266.2 mm
3). Sevo and comb anesthesia resulted in a
significantly larger contusion compared to iso, which was in line with the significantly better neurological function with iso
(sevo=4.661.3 pts.; iso=3.960.8 pts.; comb=5.161.6 pts.). The expression of inflammatory marker genes was not
significantly different at 15 minutes and 24 hours after CCI. In contrast, significantly more Iba1-positive cells were present in
the pericontusional region after sevo compared to comb anesthesia (sevo=181648/mm
3; iso=150636/mm
3;
comb=113640/mm
3). A brief episode of anesthesia, which is sufficient for surgical preparations of mice for procedures
such as delivering traumatic brain injury, already has a significant impact on the extent of secondary brain damage.
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Introduction
Traumatic brain injury (TBI) triggers a cascade of secondary
events that ultimately lead to a delayed and progressive destruction
of surrounding brain tissue, and the pathophysiological processes
of this secondary expansion are poorly understood. To examine
this essential phenomenon in more detail, standardized in vivo
models are necessary. In mice, controlled cortical impact (CCI) is
one of the most commonly applied experimental TBI models. The
CCI model is ideal to induce very reproducible primary lesions but
requires background anesthesia during the surgical preparation.
However, anesthetics alter brain metabolism, cerebral blood flow,
and physiological variables like arterial blood gases, mean arterial
blood pressure, or cardiac output [1]. Likewise, anesthetics have
neuroprotective effects when administered prior to cerebral
ischemia for several hours after insult [2,3]. Anesthesia itself may
therefore already influence secondary events like cerebral
perfusion, excitotoxicity, inflammation, and apoptosis [4], which
will lead to changes to the extent of neuronal injury and functional
outcome as demonstrated by one hour of anesthesia with different
protocols following rat TBI [5].
The impact of very brief episodes of background anesthesia on
secondary pathophysiological mechanisms has so far not been
determined. Therefore, the present study aims to investigate the
influence of sedation for 15 minutes with three common sedation
protocols (isoflurane [iso], sevoflurane [sevo] and an intraperito-
neal [i.p.] combination anesthesia [comb]) on histopathological
damage, neurological function, and cerebral inflammation in a
traumatic brain injury model in mice.
Results
Mortality and physiological parameters
All animals (male C57Bl/6N mice) survived the 15-minute or 24-
hour observation period. Physiological parameters (15 minutes after
CCI) were within the normal range and were not different between
the experimental groups (Table 1) with the exception of comb
animals,whichdeveloped areducedpH(7.2160.1)and demonstrated
an elevated paCO2 (57.064.7 mmHg, p,0.05 vs. iso or sevo). The
systolic blood pressure with comb anesthesia was significantly higher
(143633 mmHg) compared to sevo (100622 mmHg) five minutes
after CCI, but not different between sevo and iso.
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The primary lesion at 15 minutes after trauma was similar in all
groups (sevo=17.8865.53 mm
3; iso=20.4763.67 mm
3;c o m b =
19.5364.6 mm
3; Figure 1 A). Brain contusion volume increased at
24 hours from CCI in all groups (sevo=45.3269.04 mm
3;i s o =
31.4664.04 mm
3; comb=42.1168.27 mm
3; p=0.006 vs. 15 min).
Animals anesthetized by sevo (p=0.006) or comb (p=0.042)
developed a significantly larger contusion volume compared to iso
after 24 hours.
Influence of the anesthesia on functional outcome
Body weight was measured prior to surgery and 24 hours after
CCI as a general marker for well-being and was compared
to values obtained prior to trauma (sevo=25.963.6%; iso=
24.262.6%; comb=29.262%; Figure 1 C). Loss of body
weight was significantly higher in comb compared to isoflurane-
anesthetized animals (p=0.012).
All animals demonstrated an impaired neurological function at
23 hours after trauma (sevo=4.661.3 points; iso=3.960.8
points; comb=5.561.8 points). Neurological function was signif-
icantly worse with comb compared to iso (p=0.027) but not to
sevo (Figure 1 D).
Inflammatory marker gene expression after brain trauma
Expression of the inflammatory marker genes COX-2 (Figure 2
A), iNOS (Figure 2 B), and IL6 (Figure 2 C) was not signifi-
cantly different between the anesthetic protocols at 15 minutes
and 24 hours after experimental brain trauma.
Iba-1 activity
Immunoreactive glial cells were quantified as a marker for
cerebral inflammation by staining for Iba-1. Fifteen minutes after
CCI, all animals presented low level inflammation (128642 Iba-1-
positive cells/mm
3; Figure 2 D) independent of the group.
Twenty-four hours after trauma, the number of Iba-1-positive cells
in the pericontusional region increased in the sevo group (sevo=
181648/mm
3; iso=150636/mm
3; comb=113640/mm
3).The
number of Iba-1-positive cells was significantly higher in the sevo
group compared to the comb group (p=0.042).
Discussion
This study demonstrates that even brief episodes of background
anesthesia already influence secondary damage following exper-
imental brain injury. The key findings of the study are the
following: 1) sevoflurane (sevo) and the combination i.p. anesthesia
(comb) increase the extent of brain damage at 24 hours from CCI
when compared to isoflurane (iso), and, accordingly, neurological
function with comb anesthesia was significantly worse compared to
isoflurane anesthesia; 2) microglial activation was significantly
higher after sevoflurane anesthesia compared to comb; and 3)
despite differences in the extent of parenchymal damage and
microglia activation, local inflammatory marker gene mRNA
expression did not differ between the anesthesia protocols.
To investigate traumatic brain injury, multiple models have
been developed in rodents, ranging from the induction of heat or
cold lesions on the brain surface or the compression of brain
parenchyma with a piston or water cushion [6,7]. One of the most
frequently applied models is the controlled cortical impact (CCI),
which utilizes a piston to penetrate the brain at a defined velocity,
depth and impact duration. The surgery takes 10 to 15 minutes to
deliver a CCI in mice and is performed under background
anesthesia, which is then discontinued within 5 minutes after the
trauma is delivered. However, anesthesia per se may confound
data due to its effects on secondary mechanisms. In traumatic
brain injury research, the ideal anesthetic agent should fulfill the
following criteria: 1) no influence on brain lesion extent, 2) no
influence on neurological function, and 3) no influence on
secondary mechanisms such as inflammation. The study, there-
fore, evaluated the impact of current anesthetic protocols on key
experimental endpoints after CCI by comparing the typical
anesthesia protocols that are applied during experimental
procedures. Isoflurane and sevoflurane currently replace halo-
thane in laboratory practice and were therefore selected as
examples of inhalative agents. Both substances share the
advantage of fast sedation induction and termination speed but
demonstrate neuroprotective potency [8]. The protective effects
are attributed to the upregulation of nitric oxide synthase with
increased cerebral perfusion and mitochondrial ATP-regulated
potassium channel activity and reduced excitotoxic and metabolic
stress and apoptotic cell death [8]. In recent studies, intraperito-
neally injectable anesthetics have become a popular alternative to
produce surgical anesthesia with limited vascular effects. The
combination of the anesthetics fentanyl, midazolam, and mede-
tomidine was selected as an example used in spontaneously
breathing animals [9,10,11,12]. The substances can be antago-
nized specifically by naloxon, flumazenil, and atipamezol to
promptly terminate sedation within 1–3 minutes and demonstrate
little effect on cerebral perfusion and intracranial pressure [13,14].
The downside of the protocol is the use of six drugs with different
pharmacological properties. The opposing effects of the anesthetic
agents of the comb protocol impede a reliable estimation on the
impact of secondary brain damage following CCI. To date, no
published information is available on the differential effect of the
comb treatment on secondary brain damage and the underlying
mechanisms.
To determine the influence of the sedation protocols on
secondary lesion expansion, primary initial lesion volume was
determined at 15 minutes after trauma. The results demonstrate
that the primary contusion is independent of the anesthetic agent.
Over time, the brain contusion expands into surrounding healthy
brain tissue. In contrast to the primary lesion, this expansion
differs between individual anesthesia protocols. Isoflurane anes-
thesia resulted in the lowest histological damage, while sevoflurane
and comb anesthesia caused greater damage. Accordingly, animals
anesthetized with isoflurane showed the best neurological function
and the lowest body weight loss. While a recent study has shown
that the application of seven different anesthetic agents for one
Table 1. Physiological parameter.
sevo iso comb
arterial pH (15 min after CCI) 7.2560.3 7.2960.1 7.2160.1
paO2 [mmHg] (15 min after CCI) 211612 238619 131646
paCO2 [mmHg] (15 min after CCI) 39.766.8 35.563.7
$,*57.064.7
Syst. BP [mmHg] (5 min before CCI) 103624 110613 136629
Syst. BP [mmHg] (5 min after CCI) 100622 107620 *143633
Rect. Temp. [uC] (5 min after CCI) 36.160.8 36.260.8 36.060.7
paO2/paCO2=arterial O2/CO2 partial pressure determined 15 minutes after
trauma; Syst. BP=non-invasively determined systolic blood pressure; Rect.
Temp=rectal body temperature;
*p,0.05 vs. sevo,
$p,0.05 vs. iso.
doi:10.1371/journal.pone.0019948.t001
Impact of Brief Anesthesia during Experimental TBI
PLoS ONE | www.plosone.org 2 May 2011 | Volume 6 | Issue 5 | e19948hour following traumatic brain injury influenced the histopatho-
logical damage [5], the present study demonstrates for the first
time that even very brief episodes of anesthesia (10–15 minutes)
already influence secondary brain damage.
Mechanisms of anesthesia-induced alterations of secondary
brain damage are not fully understood. The present findings are in
accordance with a recent study, in which isoflurane compared to
sevoflurane given for 30 minutes after trauma reduced lipid
peroxidation more efficiently [15], which plays a crucial role in
secondary brain damage [16]. The beneficial action of isoflurane is
likely to be multifactorial and may be attributed, in part, to
cerebral vasodilation and attenuation of excitotoxicity. Isoflurane
reduces glutamate release [17], blocks NMDA receptors more
effectively than sevoflurane [18], and reduces NMDA-mediated
calcium influx [19]. Additionally, isoflurane increases cerebral
blood flow [20]. In contrast, sevoflurane-treated animals demon-
strate higher intracranial pressure (ICP) (and lower cerebral
perfusion pressure [CPP] levels) compared to isoflurane after head
trauma [21], which may contribute to the observed differences. An
increase in ICP and a reduction in CBF is known to contribute to
secondary contusion expansion after head trauma [22].
Cerebral inflammation is implicated as one of the key
parameters for secondary lesion expansion. The inflammatory
response is characterized by the early production of pro- and anti-
Figure 1. Histological brain damage and neurological function. (A) The contusion volume was determined 15 minutes and 24 hours after
experimental brain trauma (CCI). The primary lesion 15 minutes after CCI was not significantly different between the anesthetic regimens. Within
24 hours, brain contusions increased significantly in all groups. Sevo-anesthetized animals experienced a significantly larger contusion volume
compared to the isoflurane and comb groups (group size: 15 minutes, n=6 per group; 24 hours, n=8). (B) The contusion areas of all groups
obtained from 11 coronal brain sections (750-mm interval) cut from rostral (no. 1) to dorsal (no. 11) 15 minutes and 24 hours after CCI. The graph
illustrates that the secondary expansion of brain damage occurred in all brain areas (mean 6 S.E.M.). (C) The body weight was determined 24 hours
after CCI and was compared to the value obtained before trauma as the general marker for the well-being of the animals. Animals anesthetized with
comb lost significantly more body weight compared to iso. The other anesthetic regimens were not significantly different. (D) Neurological function
was determined by the neurological severity score (NSS; 0 point=no impairment; 10 points=maximal impairment, (Table 2) 23 hours after CCI. NNS
scores of comb were significantly worse compared to iso. The other groups were not significantly different. (sevo=sevoflurane; iso=isoflurane;
comb=i.p. injection of midazolam, fentanyl and medetomidine; data are presented as mean 6 S.D.; NS=not significant; p-values are adjusted for
multiple comparison by Bonferroni).
doi:10.1371/journal.pone.0019948.g001
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oxide synthase [24], and the accumulation of neutrophils in the
injured brain [25]. Despite differences at the histological level, the
expression of inflammatory marker genes did not differ between
the study groups. In contrast, the microglia were significantly more
activated after the sevo compared to the comb protocols. Although
microglia-mediated inflammation seems to be affected by the
anesthesia, similarities in the inflammatory mRNA expression
profile suggest a lack of a direct aggravating influence of
anesthetics on cerebral inflammation. A possible alternate
explanation for the observed differences in histological and
neurofunctional outcome is ‘‘preconditioning’’ by volatile anes-
thetics. In experimental stroke, exposure with 1.1 or 2.2%
isoflurane prior to ischemic stroke prevented apoptosis [26].
Exposure to volatile anesthetics 5 minutes prior to CCI may
already be sufficient to alter or ‘‘precondition’’ tissue to become
less sensitive to mechanical injury.
Physiological distinctions between the groups should also be
considered as possible explanations for the differences in
histological and neurofunctional outcomes. In this study, physio-
logical variables were not different between isoflurane- and
sevoflurane-anesthetized animals. Therefore, physiological vari-
ables alone cannot explain the difference in histological brain
damage and neurological function between sevoflurane- and
isoflurane-anesthetized animals. In contrast, differences in the
arterial blood gases and systolic blood pressure were observed
between volatile and comb anesthesia protocols. Increased paCO2
level in the comb group may result in increased cerebral blood
volume and intracranial pressure and may have contributed to the
large histological brain damage compared to isoflurane. Addition-
ally, systolic blood pressure was significantly higher in comb
animals. Improved blood pressure did not result in a smaller
contusion volume, although an increase in blood pressure may
improve collateral cerebral blood flow in injured regions [27].
Alternatively, it could also be argued that a higher systolic blood
pressure may have enhanced edema formation due to bleeding
into the traumatized brain region [28,29].
Conclusion
Selection of an appropriate anesthetic agent seems to be
essential, as initial anesthesia influences delayed secondary lesion
expansion probably because of the modulation of neuronal cell
death. Importantly, cerebral inflammation seems to be indepen-
dent of the selected anesthetic agent. Based on this study,
sevoflurane anesthesia may be superior to induce surgical
anesthesia with normal physiological parameters along with
substantial lesions to determine histological and neurological
outcome.
Materials and Methods
A total of 51 male C57Bl/6N mice that weighed between 18
and 24 g and were approximately 2 to 3 months of age (Charles
River Laboratory, Sulzfeld, Germany) were investigated. Prior to
and during experiments, the animals were cared for in compliance
with institutional guidelines of the Johannes Gutenberg-University,
Mainz. The Animal Ethics Committee of the Landesuntersu-
chungsamt Rheinland-Pfalz gave approval for all the experiments
(protocol number: G08-1-012).
Traumatic brain injury
Animals were randomly separated into three different anesthetic
regimens: those that received isoflurane (iso), sevoflurane (sevo), or
a combination (comb) of midazolam (5 mg/kg; Ratiopharm, Ulm,
Germany), fentanyl (0.05 mg/kg; CuraMed, Karlsruhe, Ger-
many), and medetomidine (0.5 mg/kg; Pfizer, Karlsruhe, Ger-
many). To ensure the same trauma severity in all animals, survival
duration was revealed after the induction of trauma (15 minute-
s=technical control or 24 hours). The comb protocol was
terminated by subcutaneous (s.c.) injection of flumazenil
(0.5 mg/kg; Hoffmann-La-Roche, Grenzach-Wyhlen, Germany),
naloxon (1.2 mg/kg; Inresa, Freiburg, Germany), and atipamezol
(2.5 mg/kg; Pfizer, Karlsruhe, Germany). Anesthesia was induced
in a bell jar filled with 4% iso or 6% sevo and maintained via
facemask (1.4% iso or 3.5% sevo in 40% O2 and 60% N2). In
animals randomized into the comb group, anesthetics were
injected intraperitoneally, and an air mixture (40% O2 and 60%
N2) was supplied via facemask in spontaneously breathing animals.
The selected dosage was the minimal amount required to inhibit
movement of the mice during the surgical procedure and was
determined in a pilot study (data not shown).
The brain trauma model was performed as previously described
[30]. Animals were placed in a stereotactic frame (Kopf Instr-
uments, Tujunga, USA) and were subjected to brain trauma by
CCI. A craniotomy (464 mm) was performed using a high-speed
drill over the right parietal cortex between the sagittal, lambdoid,
and coronal sutures. A custom-fabricated pneumatically controlled
cortical impactor (L. Kopacz, Mainz, Germany) was placed
Figure 2. Expression of inflammatory marker genes and microglia activation. A–D: The mRNA expression was determined in contused
brain tissue. Expression of the inflammatory marker genes COX-2 (A), iNOS (B), and IL6 (C) was not significantly different between the anesthetic
protocols at 15 minutes and 24 hours after experimental brain trauma (group size: naı ¨ve, n=9; 15 minutes, n=6; 24 hours, n=8; data are presented
as mean 6 S.D.). D: As a marker for activated microglia, immunohistochemical analysis of Iba-1-positive cells was performed in the pericontusional
tissue that revealed a significantly increased activation in sevo animals vs. comb (n=8 per group; sevo=sevoflurane; iso=isoflurane; comb=i.p.
injection of midazolam, fentanyl and medetomidine; native=no surgery; NS=not significant; p-values were adjusted for multiple comparison by
Bonferroni). E: Example pictures of the Iba-1-stained slides of animals 24 hours post-injury (206magnification). The number of activated microglia
was determined at the border zone adjacent to the damaged brain tissue. Iba-1-positive cells are labeled dark brown (arrows).
doi:10.1371/journal.pone.0019948.g002
Table 2. Criteria of the Neurological Severity Score (NSS).
Task Points
Presence of mono- or hemiparesis 1
Inability to walk on a 3-cm-wide beam 1
Inability to walk on a 2-cm-wide beam 1
Inability to walk on a 1-cm-wide beam 1
Inability to balance on a 1-cm-wide beam 1
Inability to balance on a round stick (0.5 cm diameter) 1
Failure to exit a 30-cm-diameter circle (for 2 min) 1
Inability to walk straight line 1
Loss of startle behavior 1
Loss of seeking behavior 1
Maximum total 10
One point is awarded for failure to perform a task.
doi:10.1371/journal.pone.0019948.t002
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impactor tip was used that had a diameter of 3 mm, an impact
velocity of 8 m/s, an impact duration of 150 ms and a brain
penetration depth of 1 mm. Immediately after cortical impact, the
craniectomy was closed with the initially removed bone and fixed
with conventional tissue glue (Histoacryl, Braun-Melsungen,
Melsungen, Germany). The wounds were closed with filament
sutures at the end of the surgery.
Rectal temperature was maintained constant at 37uCb ya
feedback-controlled heating pad (Hugo Sachs, March-Hugstetten,
Germany) and recorded 5 minutes before and 5 minutes after
CCI. At the end of the preparation, anesthesia was discontinued.
Animals that survived 15 minutes post-CCI remained on the
heating pad until their brains were removed. Mice surviving CCI
for 24 hours were placed in their individual cages and allowed to
recover for 6 hours in an incubator heated to 33uC and at a
humidity of 35% (IC8000, Draeger, Germany).
Experimental groups
Animals were randomly assigned to six trauma groups and a
native (no surgery) control group. The anesthesia was initiated
prior to surgical preparation and was terminated immediately after
CCI and wound closure to ensure a similar duration of anesthesia:
Group 1: iso +15 min survival (n=6)
Group 2: sevo +15 min survival (n=6)
Group 3: comb +15 min survival (n=6)
Group 4: iso +24 hr survival (n=8)
Group 5: sevo +24 hr survival (n=8)
Group 6: comb +24 hr survival (n=8)
Group 7: native animals (n=9, 3 animals per
anesthetic regimen)
Measurement of physiological parameters
Blood pressure was measured 5 minutes before and 5 minutes
after CCI at the tail using a modified non-invasive blood pressure
system (RTBP 2000, Kent, USA) as previously described [12].
Cuff pressure signals were recorded with a sample rate of 100 Hz
(A/D converter: PCI 9112, Adlink Technology, Taiwan; PC
software: Dasylab 5.0, measX, Germany) and analyzed offline
(Flexpro 6.0, Weisang, Germany) for systolic blood pressure. In
animals that survived 15 minutes, arterial blood samples were
drawn from the common carotid artery. Arterial blood gas
concentrations and blood glucose levels were determined with the
blood gas analyzer ABL800 BASIC (Radiometer Medical ApS,
Brønshøj, Denmark).
Histological evaluation
At the end of the observation period, the animals were
euthanized in deep anesthesia by repeating the initial anesthetic
regimen or in the native group by immediate cervical dislocation
after allocation to one of the three anesthesia regimens.
The brains were carefully removed, frozen in powdered dry ice,
and stored at 220uC. Brains were cut in the coronal plane with a
cryostat (HM 560 Cryo-Star, Thermo Fisher Scientific, Walldorf,
Germany). The first slide was defined according to the Mouse
Brain Library atlas as bregma +3.14 mm (www.mbl.org). Ten-
micron-thick sections were collected every 750 mm, placed on
Superfrost plus slides (Thermo Fisher Scientific, Germany) and
stained with cresyl violet. For mRNA quantification, tissue samples
of the right upper quadrant were collected by separation of the
remaining tissue between two intervals in the region with contused
brain tissue and were stored at 280uC. The area of both
hemispheres and contused brain tissue were determined with a
computerized image system (Optimas 6.51, Optimas Corporation,
Bothell, USA) by an investigator blinded to the group allocation.
Table 3. Specific primer and probes and optimized temperature conditions for real-time PCR.
PCR assay Oligonucleotide Sequence GenBank No.
[amplicon size, annealing temp] (59-39)
IL1b Forw: 59-gTgCTgTCggACCCATATgAg-39 NM_008361
[348 bp, 55uC, A: 10 s, E: 15 s] Rev: 59-CAggAAgACAggCTTgTgCTC-39
Red: R610-CAgCTggAgAgTgTggATCCCAAgC-Phos
FL: 59-TAATgAAAgACggCACACCCACCC-FL
IL6 Forw: 59-GAGGATACCACTCCCAACAGACC-39 NM_031168
[141 bp, 58uC, A: 10 s, E: 15 s] Rev: 59-AAGTGCATCATCGTTGTTCATACA-39 [31]
iNOS (NOS2) Forw: 59-TGTGTCAGCCCTCAGAGTAC-39 NM_010927
[312 bp, 58uC, A: 10 s, E: 15 s] Rev: 59-CACTgACACTYCgCACAA-39 [29]
Red: R610-gCTCCTCCCAggACCACACCC-Phos
FL: 59-gAAgCCCCgCTACTACTCCATC-FL
Cyclophilin A (PPIA) Forw: 59-gCgTCTSCTTCgAgCTgTT-39 NM_008907
[146 bp, 55uC, A: 10 s, E: 15 s] Rev: 59-RAAgTCACCACCCTggCA-39 [29]
Red: R610-TTggCTATAAgggTTCCTCCTTTCACAg-Phos
FL: 59-gCTCTgAgCACTggRgAgAAAggA-FL
COX-2 (ptgs2) Forw: 59-TCTTTgCCCAgCACTTC-39 NM_011198
[183 bp, 55uC, A: 10 s, E: 15 s] Rev: 59-CCTCTCCACCRATgACCTgA-39
Red: R610-ggTCCTCgCTTMTgATCTgTCTTgAA-Phos
FL: 59-CCAgTCCTCgggTgAACCC-FL
Forw=sense primer; Rev=anti-sense primer, R610=LightcyclerH Red610, Phos=phosphate, FL=fluorescein.
doi:10.1371/journal.pone.0019948.t003
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calculated based on the contusion and brain areas obtained from
11 consecutive sections with a 750-mm interval according to the
following formula: 0.75 * (A1+A2+A3+…+An).
Iba-1 activity
For immunohistochemical staining for activated microglia,
cryosections were fixed in 4% paraformaldehyde in phosphate
buffered saline and then incubated with blocking serum at room
temperature. Sections were incubated overnight at room temper-
ature with an anti-Iba-1 antibody (rabbit, 1:1,500, WAKO Pure
Chemical Industries, Osaka, Japan). The secondary antibody was
a biotinylated anti-rabbit IgG (H+L) BA-1000 (Vector Laborato-
ries Inc., Burlingame, Ca, USA). The total amount of positive
cells was counted in the cortical percontusional tissue (ROI:
0.260.3 mm) at bregma 21.28 mm according to a mouse brain
atlas (www.mbl.org) by an investigator blinded towards the group
allocation of the animals (see Figure 2 E).
Quantification of functional outcome
The before- and after-CCI functional outcome was determined
by an investigator blinded towards the experimental groups by
measuring the body weight and assessing a neuroscore. The 10-
point neurological severity score (NSS) was applied as described by
Tsenter et al. [31]. The neuroscore consists of 10 different tasks
that evaluate motor ability, alertness, balance, and general
behavior. For each failed task, the mouse receives 1 point. Healthy
mice were successful in all tasks and received 0 points. Severely
impaired animals received up to 10 points (Table 2).
RNA isolation, quality control and cDNA synthesis
RNA was isolated from brain tissue samples, which were
collected from the right upper quadrant (contused brain tissue)
during the histological processing. Samples were lysed with
RNeasy lysis buffer (Qiagen, Hilden, Germany) and homogenized
with a MM300 mill mixer (Retsch, Haan, Germany) operated at
30 Hertz for 2 minutes. Total RNA was isolated from the lysed
and homogenized cells using the RNeasy Lipid Tissue Mini Kit
(Qiagen) according to the manufacturer’s instructions and eluted
with 25 mL RNase-free water. RNA concentrations were spectro-
metrically calculated using NanoVue (GE Healthcare Europe,
Munich, Germany). Then, 0.5 mg extracted RNA was reverse-
transcribed into cDNA using the Verso
TM cDNA Kit (ABgene,
Hamburg, Germany) according to the manufacturer’s instructions.
PCR standard generation for absolute qPCR
quantification
Fragments of all applied genes were generated by PCR on a
Thermocycler gradient (Eppendorf, Hamburg, Germany). The
PCR cycle parameters were as follows: thermal activation for
10 min at 95uC and 35 cycles of PCR (melting for 45 sec at 94uC,
annealing for 45 sec at 55–65uC, and extension for 60 sec at 72uC).
The primers used [30,32] are listed in Table 3. To verify the
specificity of the PCR reactions, PCR products were electropho-
resed alongside the 50-bp DNA Molecular Weight Marker XIII
(Roche Diagnostics, Mannheim, Germany) through a 2% (w/v)
agarose gel (Invitrogen). The gels were stained with SYBR green
(Roche), and images were captured using a Kodak EDAS 120
Image System (Eastman Kodak Sa `rl, Gene `ve, Switzerland). The
PCR products were purified with the QIA quick PCR Purification
Kit (Qiagen) according to the manufacturer’s instructions, and the
DNA concentrations were determined using a NanoVue system
(GE Healthcare). The copy number was calculated and serial 10-
fold dilutions were made in the range of 1610
1 to 1610
7 copies.
Quantitative polymerase chain reaction (real-time PCR)
The cDNAs from each sample were amplified by a real-time
Lightcycler 480 PCR System (Roche). Equal amounts of cDNA
(1 ml) were used in duplicate and amplified with a LightcyclerH 480
Probes Master or LightcyclerH 480 SYBR Green I Master
(Roche). Real-time cycle parameters were as follows: thermal
activation for 10 min at 95uC and 50 cycles of PCR (melting for
10 sec at 95uC, annealing for 10 sec at 55uC (for HybProbe assays)
or, according to Table 3, extension for 15 sec at 72uC). Applied
primers and probes are listed in Table 3. A standard curve for
absolute quantification was generated with PCR DNA for each
PCR product (10
1–10
7). The absolute copy numbers of the target
genes were normalized against the absolute copy numbers of
Cyclophilin A (PPIA) as the control gene [30].
Statistical Analysis
Histological brain damage, neurological function score, gene
expression (IL6, COX-2, iNOS), and microglia activation (Iba-1)
were compared between the different anesthetics (iso vs. sevo, iso
vs. comb, and sevo vs. comb) with Wilcoxon Mann Whitney Rank
Sum tests, and p-values were adjusted for multiple comparisons
(Bonferroni adjustment). Physiologic data of each time point were
analyzed by one-way ANOVA. Results are presented as mean 6
standard deviation (S.D.). If not indicated otherwise, adjusted p-
values were considered significant at the p,0.05 level. However,
as the study was conducted in an explorative approach, all p-
values were considered as explorative.
Statistical analysis was performed with the SigmaStat 3.11
Statistical Software package (SPSS Science, USA).
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